혈관이식편 시장(2026-2030년)

The global vascular grafts market is forecasted to grow by USD 1846.8 mn during 2025-2030, accelerating at a CAGR of 7.5% during the forecast period. The report on the global vascular grafts market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of cardiovascular disorders, technological advancements in biomaterials engineering, expansion of minimally invasive procedures.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's global vascular grafts market is segmented as below:

By Product

• Endovascular grafts
• Bypass grafts
• Hemodialysis grafts
• Peripheral grafts

By Raw Material

• Polyester
• Polytetrafluoroethylene
• Polyurethane
• Biosynthetic
• Others

By End-User

• Hospitals
• Ambulatory surgical centers
• Specialty clinics

Geography

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
• Asia
• Rest of World (ROW)
• Rest of World (ROW)

This study identifies the expansion of ambulatory surgical centers as one of the prime reasons driving the global vascular grafts market growth during the next few years. Also, integration of ai diagnostics and rise in strategic industry consolidation will lead to sizable demand in the market.

The report on the global vascular grafts market covers the following areas:

• Global vascular grafts market sizing
• Global vascular grafts market forecast
• Global vascular grafts market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global vascular grafts market vendors that include Abbott Laboratories, Artivion Inc., B.Braun SE, Becton Dickinson and Co., Bentley InnoMed GmbH, BIOTRONIK SE and Co. KG, Boston Scientific Corp., Braile Biomedica, Corcym Srl, Endologix LLC, Endospan Ltd., Getinge AB, Japan Lifeline Co. Ltd., LeMaitre Vascular Inc., Lifetech Scientific Corp., Medtronic Plc, Merit Medical Systems Inc., Vygon SA, W. L. Gore and Associates Inc.. Also, the global vascular grafts market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market by Geography
  • Executive Summary - Chart on Market Segmentation by Product
  • Executive Summary - Chart on Market Segmentation by Raw Material
  • Executive Summary - Chart on Market Segmentation by End-user
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
• 2.3 Factors of disruption
• 2.4 Impact of drivers and challenges

3 Market Landscape

• 3.1 Market ecosystem
• 3.2 Market characteristics
• 3.3 Value chain analysis

4 Market Sizing

• 4.1 Market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2025
• 4.4 Market outlook: Forecast for 2025-2030

5 Historic Market Size

• 5.1 Global Vascular Grafts Market 2020 - 2024
  • Historic Market Size - Data Table on Global Vascular Grafts Market 2020 - 2024 ($ million)
• 5.2 Product segment analysis 2020 - 2024
  • Historic Market Size - Product Segment 2020 - 2024 ($ million)
• 5.3 Raw Material segment analysis 2020 - 2024
  • Historic Market Size - Raw Material Segment 2020 - 2024 ($ million)
• 5.4 End-user segment analysis 2020 - 2024
  • Historic Market Size - End-user Segment 2020 - 2024 ($ million)
• 5.5 Geography segment analysis 2020 - 2024
  • Historic Market Size - Geography Segment 2020 - 2024 ($ million)
• 5.6 Country segment analysis 2020 - 2024
  • Historic Market Size - Country Segment 2020 - 2024 ($ million)

6 Qualitative Analysis

• 6.1 Impact of AI on Global Vascular Grafts Market
• 6.2 Impact of geopolitical conflicts on Global Vascular Grafts Market

7 Five Forces Analysis

• 7.1 Five forces summary
  • Five forces analysis - Comparison between 2025 and 2030
• 7.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2025 and 2030
• 7.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2025 and 2030
• 7.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2025 and 2030
• 7.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2025 and 2030
• 7.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2025 and 2030
• 7.7 Market condition

8 Market Segmentation by Product

• 8.1 Market segments
• 8.2 Comparison by Product
• 8.3 Endovascular grafts - Market size and forecast 2025-2030
• 8.4 Bypass grafts - Market size and forecast 2025-2030
• 8.5 Hemodialysis grafts - Market size and forecast 2025-2030
• 8.6 Peripheral grafts - Market size and forecast 2025-2030
• 8.7 Market opportunity by Product
  • Market opportunity by Product ($ million)

9 Market Segmentation by Raw Material

• 9.1 Market segments
• 9.2 Comparison by Raw Material
• 9.3 Polyester - Market size and forecast 2025-2030
• 9.4 Polytetrafluoroethylene - Market size and forecast 2025-2030
• 9.5 Polyurethane - Market size and forecast 2025-2030
• 9.6 Biosynthetic - Market size and forecast 2025-2030
• 9.7 Others - Market size and forecast 2025-2030
• 9.8 Market opportunity by Raw Material
  • Market opportunity by Raw Material ($ million)

10 Market Segmentation by End-user

• 10.1 Market segments
• 10.2 Comparison by End-user
• 10.3 Hospitals - Market size and forecast 2025-2030
• 10.4 Ambulatory surgical centers - Market size and forecast 2025-2030
• 10.5 Specialty clinics - Market size and forecast 2025-2030
• 10.6 Market opportunity by End-user
  • Market opportunity by End-user ($ million)

11 Customer Landscape

• 11.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

• 12.1 Geographic segmentation
• 12.2 Geographic comparison
• 12.3 North America - Market size and forecast 2025-2030
  • 12.3.1 US - Market size and forecast 2025-2030
  • 12.3.2 Canada - Market size and forecast 2025-2030
  • 12.3.3 Mexico - Market size and forecast 2025-2030
• 12.4 Europe - Market size and forecast 2025-2030
  • 12.4.1 Germany - Market size and forecast 2025-2030
  • 12.4.2 UK - Market size and forecast 2025-2030
  • 12.4.3 France - Market size and forecast 2025-2030
  • 12.4.4 Italy - Market size and forecast 2025-2030
  • 12.4.5 Spain - Market size and forecast 2025-2030
  • 12.4.6 The Netherlands - Market size and forecast 2025-2030
• 12.5 Asia - Market size and forecast 2025-2030
  • 12.5.1 China - Market size and forecast 2025-2030
  • 12.5.2 India - Market size and forecast 2025-2030
  • 12.5.3 Japan - Market size and forecast 2025-2030
  • 12.5.4 South Korea - Market size and forecast 2025-2030
  • 12.5.5 Indonesia - Market size and forecast 2025-2030
  • 12.5.6 Thailand - Market size and forecast 2025-2030
• 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
  • 12.6.1 Brazil - Market size and forecast 2025-2030
  • 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
  • 12.6.3 UAE - Market size and forecast 2025-2030
  • 12.6.4 Turkey - Market size and forecast 2025-2030
  • 12.6.5 Argentina - Market size and forecast 2025-2030
  • 12.6.6 Colombia - Market size and forecast 2025-2030
  • 12.6.7 South Africa - Market size and forecast 2025-2030
  • 12.6.8 Israel - Market size and forecast 2025-2030
• 12.7 Market opportunity by geography
  • Market opportunity by geography ($ million)
  • Data Tables on Market opportunity by geography ($ million)

13 Drivers, Challenges, and Opportunity

• 13.1 Market drivers
  • Rising prevalence of cardiovascular disorders
  • Technological advancements in biomaterials engineering
  • Expansion of minimally invasive procedures
• 13.2 Market challenges
  • High product costs and reimbursement barriers
  • Severe post-operative complications and infections
  • Complex regulatory approval and scrutiny
• 13.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2025 and 2030
• 13.4 Market opportunities
  • Expansion of ambulatory surgical centers
  • Integration of AI diagnostics
  • Rise in strategic industry consolidation

14 Competitive Landscape

• 14.1 Overview
• 14.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 14.3 Landscape disruption
  • Overview on factors of disruption
• 14.4 Industry risks
  • Impact of key risks on business

15 Competitive Analysis

• 15.1 Companies profiled
  • Companies covered
• 15.2 Company ranking index
  • Company ranking index
• 15.3 Market positioning of companies
  • Matrix on companies position and classification
• 15.4 Abbott Laboratories
  • Abbott Laboratories - Overview
  • Abbott Laboratories - Business segments
  • Abbott Laboratories - Key news
  • Abbott Laboratories - Key offerings
  • Abbott Laboratories - Segment focus
  • SWOT
• 15.5 Artivion Inc.
  • Artivion Inc. - Overview
  • Artivion Inc. - Business segments
  • Artivion Inc. - Key offerings
  • Artivion Inc. - Segment focus
  • SWOT
• 15.6 B.Braun SE
  • B.Braun SE - Overview
  • B.Braun SE - Product / Service
  • B.Braun SE - Key offerings
  • SWOT
• 15.7 Becton Dickinson and Co.
  • Becton Dickinson and Co. - Overview
  • Becton Dickinson and Co. - Business segments
  • Becton Dickinson and Co. - Key news
  • Becton Dickinson and Co. - Key offerings
  • Becton Dickinson and Co. - Segment focus
  • SWOT
• 15.8 Bentley InnoMed GmbH
  • Bentley InnoMed GmbH - Overview
  • Bentley InnoMed GmbH - Product / Service
  • Bentley InnoMed GmbH - Key offerings
  • SWOT
• 15.9 BIOTRONIK SE and Co. KG
  • BIOTRONIK SE and Co. KG - Overview
  • BIOTRONIK SE and Co. KG - Product / Service
  • BIOTRONIK SE and Co. KG - Key offerings
  • SWOT
• 15.10 Boston Scientific Corp.
  • Boston Scientific Corp. - Overview
  • Boston Scientific Corp. - Business segments
  • Boston Scientific Corp. - Key offerings
  • Boston Scientific Corp. - Segment focus
  • SWOT
• 15.11 Corcym Srl
  • Corcym Srl - Overview
  • Corcym Srl - Product / Service
  • Corcym Srl - Key offerings
  • SWOT
• 15.12 Getinge AB
  • Getinge AB - Overview
  • Getinge AB - Business segments
  • Getinge AB - Key offerings
  • Getinge AB - Segment focus
  • SWOT
• 15.13 Japan Lifeline Co. Ltd.
  • Japan Lifeline Co. Ltd. - Overview
  • Japan Lifeline Co. Ltd. - Product / Service
  • Japan Lifeline Co. Ltd. - Key offerings
  • SWOT
• 15.14 Lifetech Scientific Corp.
  • Lifetech Scientific Corp. - Overview
  • Lifetech Scientific Corp. - Business segments
  • Lifetech Scientific Corp. - Key offerings
  • Lifetech Scientific Corp. - Segment focus
  • SWOT
• 15.15 Medtronic Plc
  • Medtronic Plc - Overview
  • Medtronic Plc - Business segments
  • Medtronic Plc - Key news
  • Medtronic Plc - Key offerings
  • Medtronic Plc - Segment focus
  • SWOT
• 15.16 Merit Medical Systems Inc.
  • Merit Medical Systems Inc. - Overview
  • Merit Medical Systems Inc. - Business segments
  • Merit Medical Systems Inc. - Key offerings
  • Merit Medical Systems Inc. - Segment focus
  • SWOT
• 15.17 Vygon SA
  • Vygon SA - Overview
  • Vygon SA - Product / Service
  • Vygon SA - Key offerings
  • SWOT
• 15.18 W. L. Gore and Associates Inc.
  • W. L. Gore and Associates Inc. - Overview
  • W. L. Gore and Associates Inc. - Product / Service
  • W. L. Gore and Associates Inc. - Key offerings
  • SWOT

16 Appendix

• 16.1 Scope of the report
  • Market definition
  • Objectives
  • Notes and caveats
• 16.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 16.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 16.4 Research methodology
  • Research methodology
• 16.5 Data procurement
  • Information sources
• 16.6 Data validation
  • Data validation
• 16.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 16.8 Data synthesis
  • Data synthesis
• 16.9 360 degree market analysis
  • 360 degree market analysis
• 16.10 List of abbreviations
  • List of abbreviations